Therapeutic Potential of Targeting Transforming Growth Factor-beta(TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer
Ghazaleh Pourali(Mashhad University of Medical Sciences), Majid Khazaei(Mashhad University of Medical Sciences), Shima Mehrabadi(Mashhad University of Medical Sciences), Nima Zafari(Mashhad University of Medical Sciences), Mahla Velayati(Mashhad University of Medical Sciences), Seyed Mahdi Hassanian(Mashhad University of Medical Sciences), Amir Avan(Mashhad University of Medical Sciences), Mina Maftooh(Mashhad University of Medical Sciences), Majid Ghayour Mobarhan(Mashhad University of Medical Sciences), Gordon A. Ferns(Brighton and Sussex Medical School)
Cited by 8
Related Papers
Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation
|Atherosclerosis|2003|140
Re‐evaluation of the existing health‐based guidance values for copper and exposure assessment from all sources
|EFSA Journal|2023|67
Microbiome as a biomarker and therapeutic target in pancreatic cancer
|BMC Microbiology|2024|50
Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective
|Life Sciences|2022|42
Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo
|Molecular Medicine|2018|31